Teladoc Health (NYSE:TDOC) Trading Down 6.4% – Time to Sell?

Teladoc Health, Inc. (NYSE:TDOC) was down 6.4% during trading on Wednesday . The company traded as low as $9.22 and last traded at $9.0860. 452,760 shares were traded during trading, a decline of 92% from the average session volume of 5,373,788 shares. The stock had previously closed at $9.71.

Wall Street Analysts Forecast Growth

TDOC has been the subject of several research reports. Canaccord Genuity Group upped their price target on shares of Teladoc Health from $10.00 to $11.00 and gave the stock a “buy” rating in a research report on Tuesday. Citigroup lifted their price objective on shares of Teladoc Health from $6.00 to $7.00 and gave the company a “neutral” rating in a report on Tuesday, May 5th. Bank of America boosted their price objective on shares of Teladoc Health from $9.00 to $10.50 and gave the stock a “buy” rating in a research note on Tuesday, July 7th. Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd. Finally, Barclays dropped their target price on Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 26th. Five analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Teladoc Health presently has a consensus rating of “Hold” and a consensus target price of $7.73.

Teladoc Health Stock Performance

The business has a 50-day moving average price of $8.00 and a 200-day moving average price of $6.51. The firm has a market capitalization of $1.57 billion, a price-to-earnings ratio of -8.95 and a beta of 2.10. The company has a quick ratio of 2.72, a current ratio of 2.80 and a debt-to-equity ratio of 0.75.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The business had revenue of $613.85 million during the quarter, compared to analyst estimates of $611.04 million. During the same period in the previous year, the business earned ($0.53) EPS. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. As a group, sell-side analysts forecast that Teladoc Health, Inc. will post -0.92 earnings per share for the current year.

Insiders Place Their Bets

In other news, insider Carlos Nueno sold 6,196 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $47,275.48. Following the sale, the insider owned 57,671 shares in the company, valued at approximately $440,029.73. The trade was a 9.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam C. Vandervoort sold 7,906 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $60,322.78. Following the transaction, the insider owned 110,261 shares in the company, valued at approximately $841,291.43. This trade represents a 6.69% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 39,195 shares of company stock worth $299,058 in the last three months. Insiders own 0.70% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Creative Planning boosted its holdings in Teladoc Health by 7.7% in the 3rd quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock worth $159,000 after buying an additional 1,462 shares during the last quarter. Versant Capital Management Inc raised its holdings in shares of Teladoc Health by 33.3% during the second quarter. Versant Capital Management Inc now owns 8,207 shares of the health services provider’s stock valued at $70,000 after acquiring an additional 2,052 shares during the last quarter. Syon Capital LLC raised its holdings in shares of Teladoc Health by 19.1% during the fourth quarter. Syon Capital LLC now owns 14,140 shares of the health services provider’s stock valued at $99,000 after acquiring an additional 2,264 shares during the last quarter. ProShare Advisors LLC lifted its position in shares of Teladoc Health by 8.2% in the fourth quarter. ProShare Advisors LLC now owns 32,532 shares of the health services provider’s stock valued at $228,000 after acquiring an additional 2,457 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Teladoc Health by 177.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after acquiring an additional 2,810 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.